Loading clinical trials...

COMPLETEDPhase 1/2NCT02758223

Prophylactic Application of Donor-derived TCM After Allogeneic HSCT

PACT is a non-randomized multicentre phase I/II study to evaluate the feasibility and safety of the prophylactic administration of donor derived TCM. Patients with Acute Myeloid Leukemia (AML) or Myel...

Lead sponsor: Wuerzburg University Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

RECRUITINGPhase 2

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

NCT07216443 · Leukemia, Myeloid, Acute, Myelodysplastic Syndromes, and more

RECRUITINGPhase 1

Preemptive CIML NK Cell Therapy After Hematopoietic Stem Cell Transplantation

NCT06138587 · Acute Myeloid Leukemia, Leukemia, and more

RECRUITING

Brain Cognitive Network Abnormalities in Anemia Patients Using fNIRS

NCT07578675 · Aplastic Anemia, Myelodysplastic Syndromes, and more

RECRUITING

Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome

NCT02269592 · Monoclonal Gammopathy of Undetermined Significance (MGUS), Myelodysplastic Syndromes, and more

RECRUITINGPhase 1/2

Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms

NCT06303193 · Myelodysplastic Syndromes

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 13, 2022Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1/PHASE2

Enrollment16

Start dateApr 2016

Last updatedJul 13, 2022

Condition

Leukemia, Myeloid, Acute Myelodysplastic Syndromes

Locations shown

University Hospital Wuerzburg - Department of Medicine II

Würzburg

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 13, 2022Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions